Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Surg. 2009 Sep;96(9):999-1004. doi: 10.1002/bjs.6669.

Follow-up may not be beneficial after treatment of grade 1 breast cancer.

Author information

  • 1Breast Unit, Guy's Hospital, London, UK. Michalis_Kontos@yahoo.com

Abstract

BACKGROUND:

Identification of women treated for breast cancer who have a low risk of locoregional recurrence or contralateral breast cancer, and who can be discharged safely from follow-up, would lower costs without compromising prognosis. This study investigated the risk of locoregional recurrence and contralateral breast cancer in women treated for grade 1 breast cancer.

METHODS:

Some 1143 women who had surgery for breast cancer were followed, and the rate of locoregional recurrence or contralateral breast cancer was determined. The risk was compared to the tumour grade.

RESULTS:

At a mean follow-up of 9.1 years, 10-year estimates of the cumulative risk of locoregional recurrence or contralateral breast cancer for grade 1, 2 and 3 breast cancer were 0.03 (95 per cent confidence interval (c.i.) 0.01 to 0.08), 0.12 (0.09 to 0.15) and 0.16 (0.13 to 0.20) respectively. Grade 1 tumours had a risk of locoregional recurrence or contralateral breast cancer of 285 (95 per cent c.i. 93 to 670) per 100,000 person-years.

CONCLUSION:

Women treated for grade 1 breast cancer could be discharged from follow-up after completion of the primary treatment, without compromising their quality of care.

(c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

PMID:
19644972
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk